Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Vadim M Zabelin

1PUBLICATIONS

8CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 01, 2023

Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent.

Radmir R Rakhimov, Aleksandr V Sultanbaev, Adel A Izmailov

Pageof 1

Frequent Collaborators

2 joint publications

Ksenia S Bakhtiyarova

1 joint publications

Radmir R Rakhimov

1 joint publications

Aleksandr V Sultanbaev

1 joint publications

Adel A Izmailov

1 joint publications

Konstantin V Menshikov

1 joint publications

Albert A Izmailov

1 joint publications

Gulshat R Gilyazova

1 joint publications

Svetlana M Izmailova

Frequent Collaborators

2 joint publications

Ksenia S Bakhtiyarova

1 joint publications

Radmir R Rakhimov

1 joint publications

Aleksandr V Sultanbaev

1 joint publications

Adel A Izmailov

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos